{"count":2,"index":{"built_at":"2026-07-27T22:41:18.942754+00:00","public_records":55311,"revision":"d94255c835e44e84ab16b7e3"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: TCF7L2 in the context of Wechseljahre"},"results":[{"answer":"The question about TCF7L2 in the context of menopause is scientifically valid, but the evidence is thin. TCF7L2 variants (e.g., rs7903146) are strongly associated with type 2 diabetes risk, and menopause involves hormonal shifts that increase diabetes susceptibility. Some studies suggest that TCF7L2 carriers may have higher postmenopausal glucose intolerance, but data are inconsistent and mostly from subgroup analyses. No specific guidelines recommend TCF7L2 screening during menopause. The effect is moderate and heavily modified by lifestyle (diet, exercise). A genetic test alone is not clinically actionable; metabolic markers (fasting glucose, HbA1c, HOMA-IR) are more relevant. Beware of overinterpretation by direct-to-consumer tests. Evidence: mixed – strong for diabetes, weak for menopause-specific context.","area":"gesundheit","canonical_id":"gesundheit:canonical-c95ce5e767d4e7d999c03917","id":"public-a6a66118171be15fddf02515","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: TCF7L2 in the context of Wechseljahre","score":22.47344024,"snippet":"The question about TCF7L2 in the context of menopause is scientifically valid, but the evidence is thin. TCF7L2 variants (e.g., rs7903146) are strongly associated with type 2 diabetes risk, and menopause involves hormonal shifts that increase diabetes susceptibility. Some studies suggest that TCF7L2 carriers may have higher postmenopausal glucose intolerance, but data are inconsistent and mostly from subgroup analyses. No specific guidelines recommend TCF7L2 screening during menopause. The effect is moderate and heavily modified by lifestyle (diet, exercise). A genetic test alone is not clinically actionable; metabolic markers (fasting glucose, HbA1c, HOMA-IR) are more relevant. Beware of ov","sources":[],"title":"Evidence check: TCF7L2 in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-a6a66118171be15fddf02515/evidence-check-tcf7l2-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The question about glucose in the context of menopause is not directly addressed in the provided knowledge base. Generally, menopause-related hormonal shifts—especially estrogen decline—can reduce insulin sensitivity, leading to higher fasting glucose and increased risk of type 2 diabetes. While MyBody-X may offer tests for glucose-related markers (e.g., HbA1c, fasting glucose) or genetic variants (e.g., TCF7L2), the evidence for their clinical utility in menopause is limited. Most guidelines recommend standard blood work and lifestyle management (diet, exercise) rather than direct-to-consumer tests. A DNA test might reveal small-effect genetic predispositions, but these are not actionable without medical context. I advise consulting a healthcare provider for proper metabolic assessment during perimenopause. Self-tests can provide awareness but not diagnosis. Evidence grade: mechanistic/unclear.","area":"gesundheit","canonical_id":"gesundheit:canonical-163709014bd5914076cdd3e1","id":"public-ca8500dffcbb57645cc44d2f","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Glukose in the context of Wechseljahre","score":20.79181774,"snippet":"The question about glucose in the context of menopause is not directly addressed in the provided knowledge base. Generally, menopause-related hormonal shifts—especially estrogen decline—can reduce insulin sensitivity, leading to higher fasting glucose and increased risk of type 2 diabetes. While MyBody-X may offer tests for glucose-related markers (e.g., HbA1c, fasting glucose) or genetic variants (e.g., TCF7L2), the evidence for their clinical utility in menopause is limited. Most guidelines recommend standard blood work and lifestyle management (diet, exercise) rather than direct-to-consumer tests. A DNA test might reveal small-effect genetic predispositions, but these are not actionable w","sources":[],"title":"Evidence check: Glukose in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-ca8500dffcbb57645cc44d2f/evidence-check-glukose-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}